Editor: Elísio Costa

Series Title: Frontiers in Drug Discovery

Erythropoietic Stimulating Agents

Volume 1

eBook: US $89 Special Offer (PDF + Printed Copy): US $163
Printed Copy: US $119
Library License: US $356
ISSN: 2542-7350 (Print)
ISSN: 2214-6210 (Online)
ISBN: 978-1-60805-748-1 (Print)
ISBN: 978-1-60805-747-4 (Online)
Year of Publication: 2013
DOI: 10.2174/97816080574741130101

Introduction

The development of new erythropoietic stimulating agents (ESAs) has significantly increased in recent years. Researchers are focused on different and interesting concepts, namely, methods to increase half-life of erythropoietin (EPO), finding different routes of administration and new ESA or modified EPO molecules. Scientific literature presents evidence that EPO has other effects beyond erythropoietic stimulation. These pleiotropic effects of EPO appear to result from the existence of two different EPO receptors (EPOR) with different affinities for EPO. The discovery of new EPO actions beyond the hematopoietic system has opened a new field of investigation with these agents. Several molecules have been developed to present the protective action, without the activation of the hematopoietic system. These agents can be potentially used in several diseases of the brain/central and peripheral nervous system, eye, heart and kidney.

This volume of Frontiers in Drug Discovery includes a revision of articles on erythropoiesis and EPO gene regulation, microRNAs and their potential contribution to the development of new therapeutic strategies, animal models for studying kidney disease-associated anemia as well as benefits/risks of ESA therapy. The biological effects of new ESA molecules, heparin-binding erythropoietin and of pHBSP, and the potential applications of ESA, are also elicited in this volume.

This volume is, therefore, a useful reference for medicinal chemists and hematologists interested in drug development and medicine related to ESAs.

Foreword

- Pp. i-ii (2)
Rui Alves
Download Free

Preface

- Pp. iii-iv (2)
Elísio Costa, Flávio Reis, Alice Santos-Silva
Download Free

List of Contributors

- Pp. v-viii (4)
Elísio Costa, Flávio Reis, Alice Santos-Silva
Download Free

Erythropoiesis: Cellular and Molecular Implications

- Pp. 3-26 (24)
Susana Coimbra, Alice Santos-Silva
View Abstract

Modulation of Erythropoietin Gene Expression

- Pp. 27-42 (16)
João C. Fernandes, Flávio Reis, Elísio Costa, Alice Santos-Silva
View Abstract

miRNAs and Erythropoietic Stimulating Agents: a New Therapeutic Approach

- Pp. 43-60 (18)
Elsa Bronze-da-Rocha
View Abstract

Animal Models of Kidney Disease-Associated Anemia

- Pp. 61-80 (20)
Patrícia Garrido, Elísio Costa, Alice Santos-Silva, Flávio Reis
View Abstract

Risks and Benefits Associated with High Therapeutic Doses of Erythropoiesis Stimulating Agents

- Pp. 81-97 (17)
Sandra Ribeiro, Elísio Costa, Flávio Reis, Alice Santos-Silva
View Abstract

Resistance to Erythropoietic Stimulating Agents in Pre-Dialysis Elderly Patients

- Pp. 98-114 (17)
Ana Cabrita, Ana P. Silva, Pedro L. Neves
View Abstract

Heparin-Binding Erythropoietin

- Pp. 115-124 (10)
Ken Toba, Masato Moriyama
View Abstract

Therapeutic Effects of Pyroglutamate Helix B Surface Peptide (pHBSP) in Disease

- Pp. 125-143 (19)
Kiran K. Nandra, Nimesh S.A. Patel, Christoph Thiemermann
View Abstract

Erythropoietin in Familial Amyloidosis ATTR V30M

- Pp. 144-159 (16)
Idalina Beirão, Paulo P. Costa
View Abstract

Effects of Erythropoietin in Skin Regeneration and Repair

- Pp. 160-179 (20)
Heiko Sorg, Reto Wettstein, Peter M. Vogt, Yves Harder
View Abstract

Effects of Erythropoietin on Blood Vessels and the Heart

- Pp. 180-204 (25)
Wolfgang Jelkmann, Steve Elliott
View Abstract

Erythropoietin and Endothelial Progenitor Cell Therapy after Myocardial Infarction

- Pp. 205-231 (27)
Kamellia R. Dimitrova, Gabriela R. Dincheva, I. Michael Leitman
View Abstract

Erythropoietin – A Possible Adjunctive Therapy for Cerebral Malaria

- Pp. 232-254 (23)
Casper Hempel, Jørgen A.L. Kurtzhals
View Abstract

No Effect of Erythropoiesis-Stimulating Agents on Solid Tumour or Lymphoma Progression?

- Pp. 255-270 (16)
Matti Aapro
View Abstract

Subject Index

- Pp. 271-294 (24)
Elísio Costa, Flávio Reis, Alice Santos-Silva
Download Free

RELATED BOOKS

.Frontiers in Anti-Infective Drug Discovery.
.Biotechnology and Drug Development for Targeting Human Diseases.
.Enzymatic Targets for Drug Discovery Against Alzheimer
.Applied Computer-Aided Drug  Design: Models and Methods.